Amvis Holdings, Inc. (TYO:7071)
610.00
-9.00 (-1.45%)
Aug 28, 2025, 3:30 PM JST
Amvis Holdings Revenue
Amvis Holdings had revenue of 12.05B JPY in the quarter ending March 31, 2025, with 19.80% growth. This brings the company's revenue in the last twelve months to 46.70B, up 26.79% year-over-year. In the fiscal year ending September 30, 2024, Amvis Holdings had annual revenue of 42.48B with 32.80% growth.
Revenue (ttm)
46.70B
Revenue Growth
+26.79%
P/S Ratio
1.28
Revenue / Employee
11.54M
Employees
4,046
Market Cap
59.60B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Sep 30, 2024 | 42.48B | 10.49B | 32.80% |
Sep 30, 2023 | 31.99B | 8.91B | 38.63% |
Sep 30, 2022 | 23.07B | 7.74B | 50.46% |
Sep 30, 2021 | 15.33B | 6.16B | 67.15% |
Sep 30, 2020 | 9.17B | 3.81B | 70.87% |
Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Chugai Pharmaceutical | 1,196.21B |
Takeda Pharmaceutical Company | 4,480.25B |
HOYA Corporation | 876.09B |
Daiichi Sankyo Company | 1,924.68B |
Otsuka Holdings | 2,401.70B |
Terumo | 1,037.94B |
Astellas Pharma | 1,944.99B |
Shionogi & | 440.50B |